where Tony began postdoctoral work on the protein products of avian retroviruses.
In 1981, the couple moved to Vancouver, Canada, where Pawson was assistant profes sor in the department of microbiology at the University of British Columbia. Pawson's lab became immediately productive, publishing important papers on oncoproteins -proteins coded by genes that have the potential to cause cancer. There, Pawson struck up collab oration with Mike Smith, a Nobelprizewin ning chemist who invented the technique of sitespecific mutagenesis that Pawson used in his SH2 discovery.
In 1985, when a research institute was launched at the Mount Sinai Hospital in Toronto (now the Lunenfeld-Tanenbaum Research Institute), Pawson joined us as one of the first appointments in its molecular and developmental biology division. With the addition of developmental biologist Alexandra Joyner and the late molecular biologist Martin Breitman, the five of us -young, ambitious and with a pioneering spirit -knew that we were building some thing important.
The division was created at a propitious time: developmental biology was about to be transformed by the latest genetic technologies from a descriptive to a mechanistic science, and cancer research was accel erating with the discovery of oncogenes, tumoursuppressor genes and related signalling pathways. The two fields were about to converge with the discov ery that the normal equivalents of viral oncogenes have crucial roles in embryo development.
Within a few years, the division grew from having just a handful of students and postdocs to having more than 100 members. Pawson was at the centre, partly because cell signalling was core to all our science, but largely because he loved to collaborate. To him, collabo ration was as much about camaraderie and friendship as it was about getting a piece of science done. Working with Tony was fun, and although he was invited to give ten times the number of talks as everybody else, he would always give credit to his collaborators.
Pawson's seminars were virtuoso performances, and they were eagerly attended. His talks and more than 450 published papers were not just assemblages of data, but elegantly presented expositions of how cells and organisms evolve, develop and function. At the time of his death, he was one of the most highly cited biomedical researchers.
When Pawson received the Heineken Prize for biochemistry and biophysics in 1998, he spoke at the ceremony in Amster dam about the joy of discovery, the privilege of working with talented young people, the potential for advances to lead to new treat ments for disease, and about the impor tance of family in a scientist's life. One could have heard a pin drop.
Our strongest memories of Tony are in those early years at the Lunenfeld, sharing our latest results, writing grants, exchang ing gossip and sharing family joys and sorrows -and watching Tony gesticulating wildly with his arms when he got excited. Biochemist whose vision of cell signalling transformed cancer research. 
